GlassScriptPhysician profile
Daniel James Veldheer
NPI 1558789990
$2,968.41
in general payments reported to CMS, 2019-2025
14 companies · $14.24 in 2025
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.94 · 2021: $28.28 · 2022: $1,987 · 2023: $900 · 2024: $22.27 · 2025: $14.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $936.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $936.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,659.25 | 2022-2023 | Intellis Adaptivestim |
| Mml US, INC. | $340.98 | 2022 | |
| Nevro Corp. | $288.43 | 2023 | Senza |
| Abbott Laboratories | $271.86 | 2023 | Proclaim |
| Boston Scientific Corporation | $144.88 | 2023 | Wavewriter Alpha Prime 16 |
| Merck Sharp & Dohme LLC | $60.17 | 2021-2025 | Bridion |
| Spr Therapeutics, INC | $40.23 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $38.12 | 2023-2024 | Ajovy, Austedo Xr |
| Vertos Medical, INC. | $35.79 | 2023 | Mild Device Kit |
| Stryker Corporation | $22.06 | 2023 | Spinejack |
| Collegium Pharmaceutical, INC. | $17.73 | 2023 | Xtampza |
| Karl Storz Endoscopy-America | $16.94 | 2019 | |
| Acacia Pharma INC | $16.25 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.72 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Veldheer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.